Patent ID: 7951807

Claim:
A compound of the general formula (I), wherein A is C 6-10 -aryl, which can be substituted with a maximum of four residues R 4 that are selected independently of one another from the group consisting of hydrogen, chlorine, bromine, iodine, fluorine, (CH 2 ) 0-2 —CN, CF 3 , OCF 3 , CONH 2 , CONH(C 1 -C 4 alkyl), CON(C 1 -C 4 alkyl)(C 1 -C 4 alkyl), NHCHO, NHCONH 2 , N(C 0 -C 4 alkylene)CONH 2 , N(C 0 -C 4 alkylene)CONH(C 1 -C 4 alkyl), NHCOCH 3 , NO 2 , (CH 2 ) 0-2 —OH, O—C 1 -C 6 alkyl, (CH 2 ) 0-2 —O—C 1 -C 4 alkyl, O—C 0 -C 4 alkylene-phenyl, phenyl, C 1 -C 6 alkyl, C 2 -C 6 alkenyl and C 2 -C 6 alkynyl, B is an aromatic or partially aromatic monocyclic or bicyclic C 6-10 , that can be substituted with the residues R 6 , R 7 , R 8 and/or R 9 , wherein R 6 , R 7 , R 8 and R 9 are selected independently of one another from the group consisting of hydrogen, chlorine, bromine, iodine, fluorine, (CH 2 ) 0-2 —CN, CF 3 , OCF 3 , CONH 2 , CONH(C 1 -C 4 alkyl), CON(C 1 -C 4 alkyl)(C 1 -C 4 alkyl), NHCHO, N(C 0-4 alkylene)CONH(C 1 -C 4 NHCOCH 3 , NO 2 , OH, O—C 1 -C 4 alkyl, (CH 2 ) 0-2 —O—(CH 2 ) 0 -3-CH 3 , O-alkylene-phenyl, phenyl, C 1 -C 6 alkyl, C 2 -C 6 alkenyl and C 2 -C 6 alkynyl, R 1 is hydrogen, C 1 -C 6 alkyl, OH, O—(C 1 -C 4 alkyl), N(C 1 -C 4 alkyl)(C 1 -C 4 alkyl), CN, CONH 2 , OCF 3 , CF 3 , Br, F, Cl, J, NO 2 , NHCHO, NHCO(C 1 -C 4 alkyl) or NHCONH 2 , R 2 is hydrogen, C 1 -C 4 alkyl, O—(C 1 -C 4 alkyl), Cl or F, R 3 is a residue (W)—(X) —(Y)—Z, wherein W is C 1 -C 4 alkylene, (C 0 -C 4 alkylene)-O—(C 0 -C 4 alkylene) or (C 0 -C 4 alkylene)-NR 15 —(C 0 -C 4 alkylene), wherein R 15 is hydrogen or C 1 -C 4 alkyl, X is CO, SO 2 , (C═NH) or (C═N—CN): and Y is a residue selected from the group consisting of wherein Y can additionally be substituted with R 10 and/or R 11 , wherein R 10 is hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, OH, O—C 1 -C 4 alkyl, O—C 1 -C 4 alkylene-phenyl, NH 2 , NH(C 1 -C 4 alkyl) or N(C 1 -C 4 alkyl)(C 1 -C 4 alkyl), R 11 is hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, OH, O—C 1 -C 4 alkyl, O—C 0 -C 4 alkylene-phenyl, NH 2 , NH(C 1 -C 4 alkyl) or N(C 1 -C 4 alkyl)(C 1 -C 4 alkyl), and Z is a residue selected from the group consisting of wherein Z can additionally be substituted with R 12 and/or R 13 , wherein R 12 is hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, OH, O—C 1 -C 4 alkyl, O—C 0 -C 4 alkylene-phenyl, NH 2 , NH(C 1 -C 4 alkyl) or N(C 1 -C 4 alkyl)(C 1 -C 4 alkyl), R 13 is hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, OH, O(C 1 -C 4 alkyl), O—C 0 -C 4 alkylene-phenyl, NH 2 , NH(C 1 -C 4 alkyl) or N(C 1 -C 4 alkyl)(C 1 -C 4 alkyl), R 14 is hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or C 0 -C 4 alkylene-phenyl, and their tautomeric, enantiomeric and/or diastereomeric forms, as well as the physiologically compatible saltsthereof.